AMJ

AMJ

Share

AMJ: #1 open access destination for HCPs & Pharma globally. Peer-reviewed journals & diverse content hub. Interviews, podcasts, webinars, infographics.

09/27/2026

Legionnaires’ disease: a hidden danger for people with cancer.

A study of 344 hospitalised adults found that cancer and immunosuppression were linked to more than twice the risk of death within 30 days. Standard urine tests also missed nearly three-quarters of confirmed cases.

The findings highlight the need for faster, more accurate diagnosis in vulnerable patients.

Read more: https://hubs.la/Q04y6j4K0

09/26/2026

Could early HIV treatment help slow biological ageing?

Researchers found that untreated HIV was linked to almost six years of accelerated biological ageing, while suppressive antiretroviral therapy slowed this process.

The findings highlight the potential long-term benefits of starting treatment early.

Read more: https://hubs.la/Q04y6hQD0

09/25/2026

Could a liver transplant affect lung health too?

A nationwide study found that liver transplant recipients had poorer lung function and more breathlessness than people without a transplant. Airflow limitation was also more than twice as likely after adjusting for key factors.

The findings highlight the importance monitoring lung health after liver transplantation.

Read more: https://hubs.ly/Q04y6fLv0

09/25/2026

Cancer and immunosuppression were each linked to more than double the risk of death from Legionnaires’ disease.

A multicentre study also found that urinary antigen testing missed nearly three-quarters of cases confirmed by PCR or culture.

Learn more: https://hubs.la/Q04yjdlh0

09/24/2026

Could a closer look at the small airways help track asthma remission?

A study found that improvements in small airway function were linked to clinical remission in adults with severe asthma receiving biologic treatment.

The findings suggest small airway testing could offer another way to monitor treatment response — but more research is needed.

Read more: https://hubs.ly/Q04y6fw60

The Many Faces of Anti-RNP Disease: A Case Series of Atypical Presentations of Mixed Connective Tissue Disease 09/23/2026

When multisystem symptoms don’t fit the usual picture, could MCTD be the missing diagnosis?

Three unusual cases reveal how mixed connective tissue disease can present with thrombocytopenia, pulmonary hypertension, or polyserositis that mimics other conditions.

Explore the cases:

The Many Faces of Anti-RNP Disease: A Case Series of Atypical Presentations of Mixed Connective Tissue Disease Mixed connective tissue disease (MCTD), first described by Gordon Sharp in 1972, is a systemic autoimmune overlap syndrome characterized...

09/23/2026

Measles is back — and vulnerable patients could be at risk.

People with autoimmune rheumatic diseases may be more vulnerable to measles, particularly when taking treatments that suppress the immune system.

With around 95% vaccination coverage needed to maintain community protection, falling coverage could leave more immunosuppressed people exposed.

Read more: https://hubs.ly/Q04y6flC0

09/23/2026

How close are we to truly personalized breast cancer care?

In our latest Quickfire Q&A, Sarah Premji of Sarah Cannon Research Institute shares insights from the American Society of Clinical Oncology 2026 congress on the research and technologies helping shape more tailored treatment strategies.

Key Takeaways:
🔹The latest insights from PALMARES-2 and OPTIMA.
🔹How biomarkers and ctDNA could inform treatment decisions.
🔹Where AI and metabolic health may fit into future oncology care.

Watch the full interview here: https://hubs.la/Q04y6b-q0

09/20/2026

Molecular profiling could replace one-size-fits-all treatment in adrenal cancer.

A multi-omic analysis of 61 patients identified four distinct molecular subtypes, each with different prognostic and therapeutic implications.

The findings highlight potential targets for immunotherapy and CDK4/6 inhibitors, supporting a more personalised approach to treatment.

Read more: https://hubs.la/Q04xKvwh0

09/19/2026

Could respiratory infections disrupt dormant cancer cells?

New research suggests influenza A and SARS-CoV-2 may trigger dormant breast cancer cells to resume growth in the lungs in mouse models.

The findings point to IL-6-driven inflammation as a possible mechanism, but human studies are needed to understand whether this could affect cancer recurrence.

Read more: https://hubs.la/Q04xKw3y0

Want your practice to be the top-listed Clinic in Miami?
Click here to claim your Sponsored Listing.

Address


1010 S Federal Highway, Hallandale Beach
Miami, FL
33009